NO20011437L - Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens - Google Patents
Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediensInfo
- Publication number
- NO20011437L NO20011437L NO20011437A NO20011437A NO20011437L NO 20011437 L NO20011437 L NO 20011437L NO 20011437 A NO20011437 A NO 20011437A NO 20011437 A NO20011437 A NO 20011437A NO 20011437 L NO20011437 L NO 20011437L
- Authority
- NO
- Norway
- Prior art keywords
- treat
- active ingredient
- eye drops
- natriuretic peptide
- lacrimal secretion
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/2242—Atrial natriuretic factor complex: Atriopeptins, atrial natriuretic protein [ANP]; Cardionatrin, Cardiodilatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Cardiology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Ophthalmology & Optometry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP27333298 | 1998-09-28 | ||
PCT/JP1999/005239 WO2000018422A1 (fr) | 1998-09-28 | 1999-09-24 | Promoteurs de secretion lacrymale ou gouttes ophtalmologiques contenant des peptides natriuretiques comme principes actifs pour traiter la keratoconjonctivite |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20011437L true NO20011437L (no) | 2001-03-21 |
NO20011437D0 NO20011437D0 (no) | 2001-03-21 |
Family
ID=17526421
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20011437A NO20011437D0 (no) | 1998-09-28 | 2001-03-21 | ÍyedrÕper for Õ fremme lakrimal sekresjon eller for Õ behandle keratokonjunktive forstyrrelser som inneholder natriuretisk peptid som aktiv ingrediens |
Country Status (7)
Country | Link |
---|---|
US (1) | US6833358B1 (fr) |
EP (1) | EP1118329A4 (fr) |
KR (1) | KR100691545B1 (fr) |
CN (1) | CN1169573C (fr) |
CA (1) | CA2345414A1 (fr) |
NO (1) | NO20011437D0 (fr) |
WO (1) | WO2000018422A1 (fr) |
Families Citing this family (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2403533A (en) | 2003-06-30 | 2005-01-05 | Orion Corp | Atrial natriuretic peptide and brain natriuretic peptide and assays and uses thereof |
DK2001518T3 (da) | 2006-03-30 | 2013-10-07 | Palatin Technologies Inc | Cykliske natriuretiske peptidfremstillinger |
US7795221B2 (en) | 2006-03-30 | 2010-09-14 | Palatin Technologies, Inc. | Linear natriuretic peptide constructs |
CN101674807B (zh) * | 2007-05-04 | 2013-03-20 | 博士伦公司 | 用于缓解、改善、治疗或预防干眼症的组合物及其制备和使用方法 |
US20080280853A1 (en) * | 2007-05-07 | 2008-11-13 | Erning Xia | Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same |
KR101533695B1 (ko) | 2009-07-23 | 2015-07-06 | 가부시키가이샤 이기스 | 피부 외용제 조성물 |
AU2010287421B2 (en) | 2009-08-27 | 2013-06-13 | Kyoko Endo | Therapeutic agent for rhinitis |
WO2011038066A2 (fr) * | 2009-09-25 | 2011-03-31 | Alcon Research, Ltd. | Nouveaux agonistes des npr-b |
CA2773949C (fr) | 2009-09-25 | 2020-11-03 | Alcon Research, Ltd. | Nouveaux agonistes des recepteurs npr-b |
TW201121995A (en) | 2009-12-18 | 2011-07-01 | Alcon Res Ltd | Novel NPR-B agonists |
CN101947307B (zh) * | 2010-08-19 | 2012-08-15 | 中山大学中山眼科中心 | 人胎盘肽在制备治疗干眼症等眼表疾病药物中的应用 |
WO2012115772A2 (fr) | 2011-02-25 | 2012-08-30 | Medtronic, Inc. | Thérapie pour néphropathie et/ou insuffisance cardiaque |
EP2750697A4 (fr) | 2011-09-02 | 2015-03-25 | Medtronic Inc | Compositions de peptides natriurétiques chimériques et procédés de préparation |
ES2656637T3 (es) | 2012-02-28 | 2018-02-27 | Ge Healthcare As | Vial con válvula de flotador libre para productos farmacéuticos estériles |
JP7051686B2 (ja) | 2016-01-08 | 2022-04-11 | アセンディス ファーマ グロース ディスオーダーズ エー/エス | 大型のキャリアー部分を有するcnpプロドラッグ |
WO2017118707A1 (fr) | 2016-01-08 | 2017-07-13 | Ascendis Pharma Growth Disorders A/S | Agonistes de cnp à libération contrôlée présentant des effets secondaires réduits |
US11311604B2 (en) | 2016-01-08 | 2022-04-26 | Ascendis Pharma Growth Disorders A/S | Controlled-release CNP agonists with low NPR-C binding |
CA3007982C (fr) | 2016-01-08 | 2023-12-19 | Ascendis Pharma Growth Disorders A/S | Agonistes de cnp a liberation controlee avec faible activite npr-b initiale |
PL3400019T3 (pl) | 2016-01-08 | 2023-01-23 | Ascendis Pharma Growth Disorders A/S | Proleki cnp z przyłączeniem nośnika w ugrupowaniu pierścieniowy |
WO2017118700A1 (fr) | 2016-01-08 | 2017-07-13 | Ascendis Pharma Growth Disorders A/S | Agonistes cnp à libération contrôlée présentant une meilleure stabilité à nep |
AU2017336253B2 (en) | 2016-09-29 | 2023-02-23 | Ascendis Pharma Growth Disorders A/S | Combination therapy with controlled-release CNP agonists |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4452818A (en) * | 1982-03-19 | 1984-06-05 | Haidt Sterling J | Extraocular method of treating the eye with liquid perfluorocarbons |
JPS60136596A (ja) * | 1983-12-26 | 1985-07-20 | Suntory Ltd | ペプチド及びこれを有効成分とする利尿剤 |
DK0385476T4 (da) * | 1989-03-01 | 1999-12-20 | Shionogi & Co | Fysiologisk aktivt polypeptid og DNA |
US5252318A (en) * | 1990-06-15 | 1993-10-12 | Allergan, Inc. | Reversible gelation compositions and methods of use |
JP2930380B2 (ja) | 1990-07-13 | 1999-08-03 | 壽之 松尾 | ブタ由来新規生理活性ペプチド(cnp―53) |
JP2809533B2 (ja) * | 1991-01-31 | 1998-10-08 | 壽之 松尾 | Cnp類似体ペプチド |
AU6360394A (en) * | 1993-03-03 | 1994-09-26 | Mayo Foundation For Medical Education And Research | Vasonatrin peptide and analogs thereof |
EP0763061B1 (fr) * | 1994-06-02 | 2002-10-30 | Forssmann, Wolf-Georg, Prof. Dr. med. | Procede et produits intermediaires utiles pour preparer des fragments de cardiodilatine, et fragments tres purs de cardiodilatine |
JPH10218792A (ja) * | 1997-02-12 | 1998-08-18 | Santen Pharmaceut Co Ltd | アンギオテンシン変換酵素阻害薬を有効成分とする涙液分泌促進および角結膜障害治療剤 |
JPH10236972A (ja) * | 1997-02-28 | 1998-09-08 | Mitsubishi Chem Corp | 涙液分泌促進剤 |
-
1999
- 1999-09-24 EP EP99944828A patent/EP1118329A4/fr not_active Withdrawn
- 1999-09-24 KR KR1020017003671A patent/KR100691545B1/ko not_active IP Right Cessation
- 1999-09-24 CN CNB998114693A patent/CN1169573C/zh not_active Expired - Fee Related
- 1999-09-24 WO PCT/JP1999/005239 patent/WO2000018422A1/fr not_active Application Discontinuation
- 1999-09-24 CA CA002345414A patent/CA2345414A1/fr not_active Abandoned
- 1999-09-24 US US09/787,164 patent/US6833358B1/en not_active Expired - Fee Related
-
2001
- 2001-03-21 NO NO20011437A patent/NO20011437D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1118329A1 (fr) | 2001-07-25 |
KR20010073181A (ko) | 2001-07-31 |
CN1169573C (zh) | 2004-10-06 |
CA2345414A1 (fr) | 2000-04-06 |
EP1118329A4 (fr) | 2004-12-15 |
KR100691545B1 (ko) | 2007-03-09 |
CN1320040A (zh) | 2001-10-31 |
US6833358B1 (en) | 2004-12-21 |
WO2000018422A1 (fr) | 2000-04-06 |
NO20011437D0 (no) | 2001-03-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20011437L (no) | Öyedråper for å fremme lakrimal sekresjon eller for å behandle keratokonjunktive forstyrrelser som inneholdernatriuretisk peptid som aktiv ingrediens | |
BG105643A (en) | Carboxylic acids and carboxylic acid isosteres of n-heterocycle compounds | |
WO2002048183A3 (fr) | Compositions de cristaux de peptides | |
CA2447924A1 (fr) | Formulations d'olopatadine a administration topique | |
MY128654A (en) | Liquid pharmaceutical composition containing an erythropoietin derivative | |
BR9907995A (pt) | Métodos imunológicos para modular miostatina em sujeitos vertebrados | |
HUP0300833A3 (en) | Gabapentin analogues for treating sleep disorders | |
NO20043663L (no) | Bicykliske aminosyrer som farmasoytiske midler | |
HK1028033A1 (en) | Sulfonamides for treatment of endothelin-mediated disorders. | |
BG105012A (en) | N-linked sulphonamides of n-heterocyclic carboxylic acids or carboxylic isosteres | |
DK0872247T3 (da) | Topisk formulering indeholdende phosphatbuffer som hudgennemtrængningsfremmer | |
IL150311A0 (en) | Sulfonamides and derivatives thereof that modulate the activity of endothelin | |
ATE497390T1 (de) | Neue therapeutische verwendung von smr-1 peptide | |
ATE249205T1 (de) | Wässrige suspension zur nasalen verabreichung von loteprednol | |
WO2002018321A3 (fr) | Inhibiteurs de proteine tyrosine phosphatase d'acide amino(oxo)acetique | |
BR0304298A (pt) | Composição contendo um ácido orgânico cosmeticamente ativo e um produto de legume | |
WO2000009103A3 (fr) | Sulfonamides a liaison n d'acides carboxyliques n-heterocycliques ou isosteres, destines a des troubles de la vision et de la memoire | |
EE200200632A (et) | Glükokortikoidravimeid sisaldavad preparaadid bronhopulmonaalsete haiguste raviks | |
HK1112738A1 (en) | Arylsulfonamides and analogues as well as use for the treatment of neuro- degenerative disorders | |
FI883643A0 (fi) | Cyklopeptider som befraemjar absorption under anvaendning pao slemhinnorna. | |
DK0973505T3 (da) | Vandigt farmaceutisk præparat, der omfatter en aktiv ingrediens, som er meget tungt opløselig i vand | |
BR9712033A (pt) | Composição farmacêutica para tratamento de doenças virais. | |
NO20032035L (no) | Terapeutiske midler for keratokonjuktivitis sykdommer omfattende farnesyleddiksyre som aktiv ingrediens | |
DE69731620D1 (de) | Neue substituierte n-methyl-n-(4-(4-(1h-benzimidazol-2-yl) (1,4)diazepan-1-yl)-2-(aryl)butyl)benzamide zur behandlung von allergischen krankheiten | |
CA2409546A1 (fr) | Peptides et derives presentant une activite de fixation, de propagation et d'ablation cellulaire |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |